New vaccine aims to block HPV cancers beyond current shots
NCT ID NCT05985681
First seen Nov 01, 2025 · Last updated Jun 05, 2026 · Updated 35 times
Summary
This early-stage trial tests a new vaccine called RG1-VLP in 18 healthy women to see if it is safe and can trigger an immune response against HPV types not covered by current vaccines. HPV is a common infection that can cause certain cancers. The goal is to find the best dose and see if this vaccine could offer broader protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Johns Hopkins University/Sidney Kimmel Cancer Center
WITHDRAWNBaltimore, Maryland, 21287, United States
-
Medical University Vienna
NOT_YET_RECRUITINGVienna, A-1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Staten Island University Hospital
WITHDRAWNStaten Island, New York, 10305, United States
-
University of Alabama at Birmingham Cancer Center
WITHDRAWNBirmingham, Alabama, 35233, United States
-
University of Wisconsin Carbone Cancer Center - University Hospital
RECRUITINGMadison, Wisconsin, 53792, United States
Contact Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.